This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wise-Draper, T. M.
Right arrow Articles by Wells, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise-Draper, T. M.
Right arrow Articles by Wells, S. I.

 Previous Article  |  Next Article 

Journal of Virology, November 2005, p. 14309-14317, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.14309-14317.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Trisha M. Wise-Draper,1 Hillary V. Allen,1 Megan N. Thobe,2 Elizabeth E. Jones,1 Kristen B. Habash,1 Karl Münger,3 and Susanne I. Wells1*

Division of Hematology/Oncology, Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, Ohio 45229,1 Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267,2 The Channing Laboratory, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts3

Received 2 June 2005/ Accepted 19 August 2005

The human DEK proto-oncogene is a nucleic acid binding protein with suspected roles in human carcinogenesis, autoimmune disease, and viral infection. Intracellular DEK functions, however, are poorly understood. In papillomavirus-positive cervical cancer cells, downregulation of viral E6/E7 oncogene expression results in cellular senescence. We report here the specific repression of DEK message and protein levels in senescing human papillomavirus type 16- (HPV16-) and HPV18-positive cancer cell lines as well as in primary cells undergoing replicative senescence. Cervical cancer cell senescence was partially overcome by DEK overexpression, and DEK overexpression was sufficient for extending the life span of primary keratinocytes, supporting critical roles for this molecule as a senescence regulator. In order to determine whether DEK is a bona fide HPV oncogene target in primary cells, DEK expression was monitored in human keratinocytes transduced with HPV E6 and/or E7. The results identify high-risk HPV E7 as a positive DEK regulator, an activity that is not shared by low-risk HPV E7 protein. Experiments in mouse embryo fibroblasts recapitulated the observed E7-mediated DEK induction and demonstrated that both basal and E7-induced regulation of DEK expression are controlled by the retinoblastoma protein family. Taken together, our results suggest that DEK upregulation may be a common event in human carcinogenesis and may reflect its senescence inhibitory function.

* Corresponding author. Mailing address: Division of Hematology/Oncology, 3333 Burnet Ave., CHRF 6501B, Cincinnati, OH 45229. Phone: (513) 636-5986. Fax: (513) 636-3549. E-mail: Susanne.Wells{at}cchmc.org.

Journal of Virology, November 2005, p. 14309-14317, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.14309-14317.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Khodadoust, M. S., Verhaegen, M., Kappes, F., Riveiro-Falkenbach, E., Cigudosa, J. C., Kim, D. S.L., Chinnaiyan, A. M., Markovitz, D. M., Soengas, M. S. (2009). Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene. Cancer Res. 69: 6405-6413 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Mintz-Cole, R. A., Morris, T. A., Simpson, D. S., Wikenheiser-Brokamp, K. A., Currier, M. A., Cripe, T. P., Grosveld, G. C., Wells, S. I. (2009). Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo. Cancer Res. 69: 1792-1799 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Morreale, R. J., Morris, T. A., Mintz-Cole, R. A., Hoskins, E. E., Balsitis, S. J., Husseinzadeh, N., Witte, D. P., Wikenheiser-Brokamp, K. A., Lambert, P. F., Wells, S. I. (2009). DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program. Am. J. Pathol. 174: 71-81 [Abstract] [Full Text]  
  • Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Burkle, A., Markovitz, D. M., Ferrando-May, E. (2008). DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress. Mol. Cell. Biol. 28: 3245-3257 [Abstract] [Full Text]  
  • Abba, M. C., Sun, H., Hawkins, K. A., Drake, J. A., Hu, Y., Nunez, M. I., Gaddis, S., Shi, T., Horvath, S., Sahin, A., Aldaz, C. M. (2007). Breast Cancer Molecular Signatures as Determined by SAGE: Correlation with Lymph Node Status. Mol Cancer Res 5: 881-890 [Abstract] [Full Text]  
  • Johung, K., Goodwin, E. C., DiMaio, D. (2007). Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence. J. Virol. 81: 2102-2116 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Allen, H. V., Jones, E. E., Habash, K. B., Matsuo, H., Wells, S. I. (2006). Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions. Mol. Cell. Biol. 26: 7506-7519 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»